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Optimal   Insulin Injection Control for Blood
Glucose Regulation in Diabetic Patients
Frederick Chee, Andrey V. Savkin, Tyrone L. Fernando*, and Saeid Nahavandi
Abstract—The theory of optimal control has the feature of
minimizing the worst-case gain of an unknown disturbance input.
When appropriately modiﬁed, the theory can be used to design a
“switching” controller that can be applied to insulin injection for
blood glucose (BG) regulation. The “switching” controller is de-
ﬁned by a collection of basic insulin rates and a rule that switches
the insulin rates from one value to another. The rule employed an
estimation of BG from noisy measurements, and the subsequent
optimization of a performance index that involves the solution of a
“jump” Riccati differential equation and a discrete-time dynamic
programming equation. With an appropriate patient model, sim-
ulation studies have shown that the controller could correct BG
deviation using clinically acceptable insulin delivery rates.
Index Terms—Dynamic programming, H-inﬁnity control, hy-
brid dynamical systems, insulin infusion, jump Riccati differential
equation, optimal control.
I. INTRODUCTION
THE PROBLEM of closed-loop blood glucose (BG) levelregulation has been a subject of investigation for decades,
with studies conducted both in the mathematical (see, e.g.,
[1]–[3], etc) and empirical framework (see, e.g., [4]).
While the empirical framework involved clinical experience
and knowledge, mathematical framework used mathematical
models (that describe the intrinsic glucose regulation performed
by the endocrine pancreas) to devise appropriate schemes for
the regulation of BG. Of particular interest is the theory of
control, which has a distinctive feature of minimizing the
worst-case gain for an arbitrary unknown disturbance.
control approach has proved to be a very powerful robust
control design technique in modern control engineering (see,
e.g., [5] and [6]). The problem of clinical BG control ﬁts
into the control framework because the glucose-insulin
dynamics of the patient can be considered as a continuous-time
system with unknown disturbance input (e.g., meal). However,
standard linear control theory is not applicable, because
of the constraints generally found in the clinical environment.
Particular to BG regulation via the intravenous insulin infusion
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route, clinical practice only infused insulin from a bounded set
of rates, in ﬁxed step size within the range, and at set intervals.
To address the constraints, the results and ideas of [7], [8] were
applied to extend the control theory to the nonlinear case
of switched output feedback controllers.
In this paper, the design of an optimal insulin injection
“switching” controller is described. The controller is deﬁned by
a collection of given insulin infusion rates which are called basic
control vectors, and the control strategy is a rule for switching
from one basic control vector to another. The goal of the con-
trol is to achieve a level of performance deﬁned by an integral
performance index similar to the requirement in standard
control theory (see,, e.g., [5], [6], and [8]). The switching rule is
computed by solving a Riccati equation of the game type, and
a discrete dynamic programming equation. Since dynamic pro-
gramming equations and type Riccati equations are well
known in modern control theory, this paper shows that the
control theory, when suitably modiﬁed, provides an effec-
tive framework for regulating BG in diabetic patients.
II. METHODOLOGY
A. Optimal Switching Control
Let be the BG sampling interval, and and be
given integers such that insulin delivery is adjusted every
over the interval . Consider the time-varying linear
continuous-time system with discrete measured output deﬁned
on the time interval
(1)
where is the state, is the external glucose
disturbance input, is the insulin infusion rate (i.e.,
control input), is the continuous controlled output,
is the discrete controlled output, is
the sensor BG measurement output, is the sensor noise,
, , , and are bounded piecewise continuous
matrix functions, and and are matrix sequences.
Let the control inputs be
(2)
where are insulin infusion rates that
are called basic control vectors. Consider the following class of
output feedback controllers.
Let be a function which maps from the set of the
BG measurements output to the set of symbols
. Then, for any sequence of such functions
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, we will consider the following dynamic nonlinear
output feedback controller:
(3)
As above, the control strategy is a rule for switching from
one basic control vector (2) to another. Such a rule constructs a
symbolic sequence from the output measurement .
The sequence is called a switching sequence.
Deﬁnition 1: Let be a given number. If there exists a
controller of the form (2) and (3) such that
(4)
where the supremum is taken over all solutions to the closed-
loop system (1) and (3) with the initial condition
and arbitrary , , then the output feedback
control problem with the disturbance attenuation is said
to have a solution via the controlled switching with the basic
control vectors (2).
The problem in (4) is not a standard control problem
with transient (see, e.g., [9]), but has the following distinctive
features:
1) the class of controller under consideration consists of
those that take values in a given ﬁnite set;
2) the underlying system is continuous-time whereas the
measured output data are available only at discrete sam-
pling instants, and the control input is piecewise constant.
Notation 1: Let be a given matrix or vector function
which is right continuous and may be left discontinuous. Then
denotes the value of just before , i.e.,
Our solution to the above problem involves the following Ric-
cati differential equation which contains jumps in its solution:
(5)
Also, we consider a set of state equations of the form
(6)
The jump Riccati differential equation being considered
in this paper is similar to those in [9], and it behaves like
a standard Riccati differential equation between sampling
instants. However, at the sampling time, its solutions exhibit
ﬁnite jumps [9]. The jump state equation also exhibits similar
jump behavior. Riccati differential equation of this type have
been widely studied in the theory of control and there exist
reliable methods for obtaining solutions.
Notation 2: Let be a given function from to and




where the supremum is taken over all solutions to the system
(6) with arbitrary inputs , and initial condition
. Here denotes the standard Euclidean norm.
Now we are in the position to present the main result of this
section. The main result will be given in terms of the existence
of suitable solutions to a Riccati equation of the ﬁltering
type and a dynamic programming equation. If such solutions
exist, then it is shown that they can be used to construct a cor-
responding controller.
Theorem 1: Consider the system (1) and the basic vectors
(2). Let be a given number, and let be deﬁned by
(7). Suppose that the solution to the jump Riccati (5) with
initial condition is deﬁned and positive deﬁnite on the
interval , and the dynamic programming equation
(8)
has a solution for such that .
Furthermore, let be an index1 such that the minimum
in (8) is achieved for , and be the solution to
the (6) with initial condition . Then, the controller
described by (2) and (3) associated with the switching sequence
where solves the output feedback
control problem (4) with the disturbance attenuation .
The solution to the discrete-time dynamic programming
equation, such as (8) above, has been the subject of much
research in the ﬁeld of optimal control theory. Furthermore,
many methods of obtaining numerical solutions have been
proposed for speciﬁc optimal control problems.
Proof: In order to prove this theorem, we will use the fol-
lowing lemma.
Lemma 1: Let and be given vector functions.
Suppose that the solution to the Riccati (5) with initial
1In another word,      signiﬁes the index into   (see (2) and (3)) asso-
ciated with a particular starting point  that gives a minimum in (8).
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condition is deﬁned and positive deﬁnite on the in-
terval . Then, the condition
(9)
holds for all solutions to the system (1) with and
if and only if
(10)
for the solution to the (6) with and
and initial condition .
a) Proof of Lemma: Given an input-output pair
, if condition (9) holds for all vector functions
, and satisfying (1) with and such that
(11)
then, substitution of (11) into (9) implies that (9) holds if and
only if
(12)
for all , where is de-
ﬁned by
(13)
and is the solution to system (1) with disturbance input
and boundary condition .
Now consider the following minimization problem:
(14)
where the minimum is taken over all and connected by
system (1) with the boundary condition . This
problem is a linear quadratic optimal tracking problem in which
the system operates in reverse time.
To convert the above tracking problem into a tracking
problem of the standard form, ﬁrst deﬁne to be the
solution to the state equations
(15)
Now let . Then, it follows from (1) and (15)
that satisﬁes the state equations
(16)
where . Furthermore, the cost function (13) can be
rewritten as
(17)
where . Equations (16) and (17)
now deﬁne a tracking problem of the standard form where
and are all treated as reference inputs.
The solution to this tracking problem is well known in the lit-
erature (e.g., see [10, Section 6.3]). If the jump Riccati equation
(5) has a positive-deﬁnite solution deﬁned in with ini-
tial condition , then the minimum in will
be achieved for any and . Furthermore, bymaking use of
the result from [11] which dealt with the problem of estimating
the state of a linear dynamic system using noise-corrupted ob-
servations, we can eliminate the term in (17) to arrive at
(18)
where is the solution to state equations
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with initial condition . By letting
and using the fact that , (18) can be
rewritten as
(19)
where is the solution to state (6) with initial condition
. From this we can conclude that condition (9) with
a given input-output pair is equivalent to the
inequality (10). This completes the proof of the lemma.
b) Proof of Theorem 1: From the dynamic programming
optimality principle (see, e.g., [12]), (8) implies that for the con-
troller associated with the switching sequence in the
statement of the theorem, we have
(20)
for the solution to the (6) with the initial condition
and and connected by the corresponding controller.
According to Lemma 1, the condition (20) implies that the in-
equality (9) holds for the closed-loop systemwith the initial con-
dition . Finally, (9) is equivalent to (4). This completes
the proof of the theorem.
B. Implementation
Let the glucose-insulin dynamics of a patient be described by
(21)
where is the BG concentration at time ;
is the blood insulin concentration from the basal
value; is the rate of exogenous glucose
infusion; is the rate of exogenous
insulin infusion per unit blood volume; and , , , , and
are described in [13]–[15].
The model (21) is a modiﬁed Minimal Model, where the
endogenous insulin secretion in the original (nonlinear) Min-
imal Model [13] has been removed, and replaced by the term
(see [14]). The conversion factor allowed to be
described in terms of (rather than ), and
in consistency with clinical convention of insulin delivery rate
prescription.
The nonlinear model (21) can be linearized and used in the
design of the optimal “switching” controller described in
Section II-A. Using the steps in [16], the linearized model is
(22)
where and are the nominal values of and around
a chosen operating condition at time , respectively. It can be
shown that for model (22) to be equivalent to model (21) re-
quires and .
A rearrangement of (22) gives
(23)
which identiﬁes with the functions , , , and
in the continuous-time system of (1). With these functions now
deﬁned, the “switching” controller can be designed, and used to
calculate an insulin rate at each insulin prescription instance, in
the following steps:
1) Generate the sequences of the “jump” Riccati equation
of (5) over the control horizon.
2) Generate the sequences of the “jump” state estimator
of (6) for all possible , and sequences of based
on all possible sequences of that are likely to occur
during the controller’s operation.
3) Using the cost function (7) and the dynamic programming
(8), calculate the minimum cost associated with the tra-
jectories taken by for each initial condition
, , beginning with
.
4) At the end of the dynamic programming process, the op-
timal path would be found, and the associated insulin rate
to be prescribed would be obtained.
C. Simulation
1) Comparison With MPCSE: The performance of the
“switching” controller was compared to a Model Predictive
Controller with State Estimation (MPCSE) (see [3], [17]). The
internal model structure was
(as in [3]) where the Kalman ﬁlter gain was computed with
The functions and are the discrete counterparts of
and in (23), converted using the MPC toolbox in Matlab®
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TABLE I
PARAMETERS USED FOR THE CONTROLLER IN THE SIMULATION
R13 (Mathworks, Inc). The Kalman ﬁlter was tuned with
, , and .
A quadratic objective of the form
(24)
was used with sampling time , , ,
, , , and
(see [18]). To allow more insulin moves, we set
U/h but only the ﬁrst calculated insulin
move for was implemented. As in [17], we set
.
D. Controllers Simulation
Simulation studies involving both the “switching” con-
troller and MPCSE controller were performed using a “virtual
patient”, which was a nonlinear pharmacokinetic/pharma-
codynamic compartmental model of Type I diabetic patient
(Sorensen’s model). The model’s parameters were set the same
as those used in [19] and [20], and with the endogenous insulin
secretion set to zero. Due to our familiarity with the Intensive
Care Unit (ICU) setting, we compared both controllers in terms
of their responses to a common ICU clinical situation where a
patient has a high BG on admission, and later required external
glucose infusion as part of routine clinical treatment. The
external glucose was infused directly into the patient’s body
through the venous line.
The model used internally by both the “switching” and
MPCSE controllers was (23) with the last term set to zero (i.e.,
) for simplicity.
Both controllers were given noisy BG readings, ,
which was generated by ﬁrst adding Gaussian noise of ampli-
tude to every 10 sec, and then taking an
average every 5 min. Both controllers were only started 1 h into
the simulation, and thereafter programmed to calculate an in-
sulin rate every 30 min, in line with the action time of the insulin
used in the ICU environment. During the time, was also up-
dated to . Simulations were conducted using Matlab®
R13 (Mathworks, Inc), and the parameters chosen for the con-
troller are summarized in Table I.
The value of the parameter was chosen to satisfy (10), while
was tuned to give a desirable simulation output. Both glu-
Fig. 1. Both controllers managed to normalize and keep BG near the target
level of 81mg/dl     . The black solid line shows the BG excursion
under no control.
cose and insulin infusion rates per unit blood volume (i.e.,
and respectively) were calculated assuming the plasma
space is 5% of body weight.
III. RESULTS AND DISCUSSION
Given that a patient’s glucose-insulin dynamics can be
represented mathematically, both the MPCSE and the
“switching” controllers made use of this mathematical model
to calculate an insulin infusion rate that would result in BG
being normalized in an optimal fashion. For MPCSE, the BG
normalization process is optimized in the sense of minimizing
the performance index [see (24)] which considered both the BG
and the use of insulin. For the “switching” controller, BG
is normalized in the sense of minimizing a performance index
that takes into account the worst-case scenario of the external
glucose infusion and the ﬁnite set of insulin rates [see (7)].
In the simulation, both the “switching” controller and the
MPCSE controller (with the chosen parameters) normalized the
BG in an unchallenged environment, with the BG settling near
the target level of 4.5 mmol/l (Fig. 1). Similarly, when external
glucose infusion was given, both controllers were able to keep
the BG around the target level (Fig. 2) despite relying on noise-
corrupted BG values as inputs. However, when the noise-cor-
rupted BG values were delayed by 30 min (before being used by
the controllers), the BG managed by MPCSE controller began
to show larger oscillations (Fig. 3), when compared to the BG
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Fig. 2. When challenged with external glucose infusion, both the “switching”
controller and MPCSE controller managed to keep the BG near the target level
of 81 mg/dl     . Both controllers were started at   	
, and
both used BG samples that were corrupted with noise (not shown on MPCSE
for clarity).
Fig. 3. A delay in the arrival of BG samples to the MPCSE controller caused
a larger oscillation in BG above the target level of 81 mg/dl      
compared to the BG regulated by the “switching” controller. Both controllers
were started at   	
 , and both used BG samples that were corrupted
with noise as well as delayed by 30 min (not shown on MPCSE for clarity).
regulated by the “switching” controller. This result suggested
the applicability of the “switching” controller in BG regula-
tion where BG measurement could be delayed by as much as
30 min. The parameters and
for MPCSE controller were the same across all the ﬁgures. The
target level2 of 81 mg/dl was chosen with ref-
erence to the recommended BG range deﬁned in [21].
By using a different model for the controller design (to
those of simulation), a model-mismatch was introduced. In the
simulation, the impact of model-mismatch was minimized by
2To allow a nonzero target BG to be set in the “switching” controller, an extra
term                  was added to the result
of 	 in (8).
bringing closer the behavior of both models through parameters
adjustment (and adjusting for the sensitivity of both models to
the externally infused insulin). Attention needs to be paid to
the issue of model-mismatch when designing the “switching”
controller for different settings, due to the optimal tracking
nature of the algorithm [see (19)].
Despite the performance of the “switching” controller
seen in Figs. 2 and 3, it came at the expense of involved proce-
dures required prior to its deployment. The tuning of the param-
eter and the compensation for model-mismatch are by far
an ad hoc (and time-intensive) process. Also, the lead time to
the deployment of the controller depends on the time required
to complete the calculations of all the possible paths taken by
under all possible patterns of and . This amounts
to trajectories, where is the number of
levels which the external glucose infusion can take, and
is the number of insulin rates chosen.
The difference between the control algorithm discussed in
this paper to those of [19] and [20] is the context in which it
is applied. The “switching” controller was designed for ICU
settings where insulin rates were chosen from a ﬁnite set, and
infused intravenously at set intervals using a bedside medical
infusion pumps (e.g., IMED® Gemini PC-1 fromAlarisMedical
System, San Diego, CA), as opposed to continuous insulin
infusion as described in [19] and [20].
Although the “switching” controller could be extended to the
case where subcutaneous insulin injection is preferred, the dy-
namics of subcutaneous route (e.g., delay in insulin activity)
needs to be taken into consideration, and this requires corre-
sponding adjustment to the internal model and the controller
parameters. Techniques to overcome the aforementioned com-
plex procedures (and adjustments) would be desirable before an
investigation of the “switching” controller in real-life clinical
study could take place.
IV. CONCLUSION
optimal control theory was modiﬁed and applied
to insulin injection BG regulation, where an optimal
“switching” controller was designed and used to minimize the
BG deviations from the target levels in the sense of worst-case
gain, under simulation and in the presence of noisy BG mea-
surements. Simulation result showed that with an appropriate
patient model, the “switching” controller can regulate BG using
clinically acceptable insulin delivery rates.
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